Compliance marketplaceHow Cruxi worksFor compliance providersDeal Desk Regulatory Dashboard Free QMSR Scan Consultant Dashboard Provider Dashboard Get Listed – Consultant Get Listed – Provider
Deal Desk

Marketplace & guides

Medical Device Deal Desk Medical Device M&A (Deal Paths) Medical Device Acquisitions Medical Device Acquisitions (Marketplace) Medical Device Company for Sale Distribution Opportunities Medical Device Exit Options Post Buying Interest List an Opportunity Acquisition & Distribution (Long Guide)
510(k) & Regulatory

Regulatory Services

Free 510(k) Device Assessment 510(k) Regulatory Pathway Assessment 510(k) Modification Assessment 510(k) Traditional Submission QMSR / ISO 13485 Readiness Platform Free QMSR Readiness Scan FDA Consultant & Medical Device Consulting 510(k) Cybersecurity Consultants Los Angeles Free 510(k) Checklist Clinical Trial Insurance (UK, EU, US) Clinical Trial Insurance Cost Calculator

510(k) Services

FDA 510k Consultant Classification Predicate Analysis Regulatory Assessment eSTAR Editor Packaging

Electrical Safety

Arc Flash & One-Line Bids As-Built Electrical Drawings Arc Flash Study Quote & Cost 510(k) Electrical Safety & EMC Testing

510(k) Resources

510(k) Demo Project FDA Database for Research Regulatory Analytics eSTAR Guide FDA eSTAR Templates Predicate Analysis Substantial Equivalence Cybersecurity (SAMD) Risk Analysis (ISO 14971) Fees & Timeline Labeling & IFU FDA 510k Consultant vs AI Checklist Guide

510(k) Microservices

Classification Matching Predicate Finding Regulatory Assessment RTA Check

AI Knowledge Base

AI Literature Review Generator Dissertation Literature Review Systematic Review Software Free Citation Generator Universal Toolbar
EU/UK Representatives

Browse Directories

All Provider Directories FDA 510(k) Submission Services marketplace FDA 510(k) Consultant Directory

Platform Directories

EUDAMED M2M Providers eIFU & Implant Card Platforms FDA GUDID Submission Tools

EU/UK Data & Privacy Reps

GDPR Article 27 Representative Do I Need a GDPR Article 27 Representative? GDPR Article 27 Cost Calculator Article 27 Representative Services Article 27 Pricing Comparison GDPR Article 27 Representative List Swiss FADP Representative Do I Need a Swiss FADP Representative? Swiss FADP Representative Cost Calculator Swiss FADP Representative List GPSR Responsible Economic Operator Do I Need a GPSR Responsible Person? GPSR Cost Calculator GPSR FAQs GPSR Marketplace Listing Readiness Calculator GPSR Technical File Readiness Scorecard GPSR Economic Operator Risk Estimator WEEE / EPR Compliance VAT Fiscal Representative DSA Article 13 Legal Representative REACH Only Representative

EU Cosmetics

EU Cosmetics Responsible Person EU/UK Responsible Person (RP/UK RP) CPSR Support PIF Preparation CPNP/SCPN Support Regulatory Consulting + Formula Compliance Testing Coordination & Management Cosmetics RP List Cosmetics Compliance Tools (EU/UK) Cosmetic Launch Diagnostic (60 sec) EU Ingredient Scan EU Claims Risk Scan Amazon Suppression Diagnosis Cosmetic Contract Manufacturing Manufacturing Tools & Guides Manufacturing RFQ Template Generator Private Label Cost Calculator Capability Matcher Wizard
EU Medical & Global Reps

EU/UK Medical Representatives

EU Authorized Representative Do I Need an EU Authorized Representative? EU Authorized Representative Cost Calculator EU Authorized Representative List UK Responsible Person Swiss Authorized Representative Swiss CH-REP Provider Directory Do I Need a CH‑REP? CH‑REP Cost Calculator CH-REP Mandate Scope Gap Calculator CH-REP Transition Timeline Calculator CH-REP Annual Budget Calculator PRRC as a Service Do I Need a PRRC? PRRC Cost Calculator PRRC List

Medical Device Support

EUDAMED Registration Support Importer & Distributor Compliance FDA QMSR Transition & Inspection Readiness eQMS Software Comparison Medical Device Cybersecurity EU AI Act Authorized Representative (GPAI) EU AI Act High-Risk AI Compliance EUDAMED Onboarding & Data Registration

Non-EU Regulatory Reps

FDA U.S. Agent FDA U.S. Agent Cost Calculator U.S. Agent Compliance Checker U.S. Agent Selection Scorecard FDA U.S. Agent List CBAM Verification AU TGA Sponsor Japan MAH / DMAH Brazil ANVISA Local Representative Compare +50 Brazil ANVISA Local Rep Providers ANVISA Local Representative Total Cost Calculator ANVISA Registration Timeline Risk Estimator ANVISA Documentation Readiness Scorecard ANVISA Portuguese Labeling Readiness Calculator ANVISA Change Impact Calculator ANVISA Post-Market Workload Calculator
Testing & Enforcement

Testing Services

Electrical Safety + EMC Testing (IEC 60601) Wireless / RF Testing (FCC / RED / ISED) Biocompatibility Testing (ISO 10993 Program) Sterilization + Microbiology Validation Packaging + Shelf-life + Distribution Testing Usability / Human Factors Testing

FDA Enforcement & Recall

FDA Import Alert & Detention Assistance Form 483 Response Team Form FDA 483 Response Provider Directory Form FDA 483 Readiness Calculator Form FDA 483 CAPA Timeline Calculator Form FDA 483 Remediation Cost Calculator Recall & 21 CFR 806 Support Recall & 21 CFR 806 Provider Directory 21 CFR 806 Reportability Decision Calculator Recall Action Timeline Calculator Recall & 806 Remediation Cost Calculator

FDA U.S. Agent Information

Medical Device Establishment Registration 21 CFR 807.40 Requirements U.S. Agent vs Official Correspondent Change U.S. Agent in FURLS U.S. Agent Address Requirements Confirm Notification Receipt Code U.S. Agent Role for Inspections U.S. Agent for IVD Manufacturer U.S. Agent for Contract Manufacturer U.S. Agent Cost Per Year Affordable U.S. Agent Service U.S. Agent for Foreign Drug Establishment 21 CFR 207.69 U.S. Agent Food Facility Registration U.S. Agent Food Facility Renewal Confirmation

Cost Calculators

Biocompatibility Testing Cost Calculator Biocompatibility Testing Labs in India EU/UK Cosmetics RP Cost Calculator
Company & Legal
About Cruxi Contact Pricing & Credits Editorial Posting & Sponsorships Blog Careers

Use Cases

Medical Device 510(k) Submission QMSR / ISO 13485 Readiness Free QMSR Readiness Scan PhD & Masters Students Medical Research Academic Writing Legal Teams

Consulting & Resources

FDA 510k Consultant Network FDA Consultant Near Me & Medical Device Consulting 510(k) Cybersecurity Consultants Los Angeles Find 510k Consultants by Specialty FDA Mock Audit Consultants ISO 13485 Consultants ISO 14971 Consultants 510k Consultant Pricing Models 7 Red Flags When Hiring a 510k Consultant Combine 510k Consultants with AI Tools How to Scope a 510k Consultant Project

General Resources

Traditional vs AI Methods Features FAQ 510k Consultant Engagement Guide (PDF)

Legal & Policies

How Cruxi Protects Your Data Security GDPR Compliance Privacy Policy Compliance & Contacts Trust & Listings Cookie Policy Subprocessors EU/UK Article 27 Representative Data Subject Request Data Processing Agreement Terms of Service Consultant Terms Provider Terms Book Now T&C (Clients) Book Now T&C (Providers) Refund Policy Payment Terms Credit Usage Policy Cancellation Policy Support Policy

For Consultants

Apply to Consultant Network

For Service Providers

Join Provider Network Apply Now

Account

Provider Dashboard Consultant Dashboard
About Contact Pricing Blog All Directories Privacy Terms

Ingredient source facts

Benzyl salicylate: EU cosmetic annex conditions and formula evidence

Benzyl salicylate has identifier matches to Annex III in the acquired 18 May 2026 EU Cosmetics Regulation text. The table distinguishes the substance identity, product-use conditions and recorded limits. Confirm the exact substance/group scope, formula concentration and intended use before applying an entry. This does not certify formula safety or settle Great Britain requirements.

Evidence retrieved 2026-10-06. Source versions and topic-specific limits are listed below.

Exact legal-entry matches and product-use conditions

Exact checksum-valid CAS and/or exact EC identifier in preserved legal identity cells. Group and substance scope are still conditional.

Each line below retains its own concentration basis, conditions and warnings. Blank source cells mean no condition was recorded in that cell; they do not establish unrestricted use.

Annex III · Entry 75

Recorded identity: 2-hydroxybenzoic acid phenylmethyl ester ( 46 )

Matching CAS: 118-58-1 · Matching EC: 204-262-9

Product use / body siteMaximum concentration and basisOther conditionsWarningsSource
(a) Fragrance products (hydroalcoholic and non-hydroalcoholic, spray and non-spray)(a) 4 %The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.Blank in source[2]
(b) Rinse-off skin and hair products (except shower gel/bath products)(b) 0,5 %The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.Blank in source[2] [4]
(c) Shower gel/bath products(c) 1,3 %The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.Blank in source[2] [5]
(d) Leave-on skin and hair products (non-spray/non-aerosol) (except body lotion)(d) 0,5 %The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.Blank in source[2] [6]
(e) Leave-on hair products (spray/aerosol)(e) 0,5 %The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.Blank in source[2] [7]
(f) Body lotion(f) 0,7 %The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.Blank in source[2] [8]
(g) Face make-up and make-up remover products(g) 0,2 %The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.Blank in source[2] [9]
(h) Oral products(h) 0,004 %The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.Blank in source[2] [10]
(i) Deodorant products (spray/aerosol)(i) 0,91 %The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.Blank in source[2] [11]

Linked notes for this entry

  • ( 46 ) From 1 January 2027 cosmetic products containing these substances and not complying with the restrictions shall not be placed on the Union market. From 1 July 2028 cosmetic products containing these substances and not complying with the restrictions shall not be made available on the Union market. [3]

The consolidated text is a dated reference. Current amendments, corrigenda and applicability dates must be checked. EU evidence does not resolve Great Britain rules.

Known facts and deciding inputs

Known context: EU. Ingredient identity is recorded; concentration, intended use, exposure and current legal conditions still need checking.

Source factRecorded valueWhat to check
INCI / recorded nameBenzyl salicylate [1]Check identity, concentration, exposure and use against the current legal annex and any amendments.
Common ingredients glossary nameBenzyl salicylate [1]Check identity, concentration, exposure and use against the current legal annex and any amendments.
CAS identifiers118-58-1 [1]Check identity, concentration, exposure and use against the current legal annex and any amendments.
EC identifiers204-262-9 [1]Check identity, concentration, exposure and use against the current legal annex and any amendments.
CosIng annex referenceIII [1]Check identity, concentration, exposure and use against the current legal annex and any amendments.
CosIng reference entry75 [1]Check identity, concentration, exposure and use against the current legal annex and any amendments.
maximumConcentration(a) 4 % (b) 0,5 % (c) 1,3 % (d) 0,5 % (e) 0,5 % (f) 0,7 % (g) 0,2 % (h) 0,004 % (i) 0,91 % [1]Check identity, concentration, exposure and use against the current legal annex and any amendments.
productTypeBodyParts(a) Fragrance products (hydroalcoholic and non-hydroalcoholic, spray and non-spray) (b) Rinse-off skin and hair products (except shower gel/bath products) (c) Shower gel/bath products (d) Leave-on skin and hair products (non-spray/non-aerosol) (except body lotion) (e) Leave-on hair products (spray/aerosol) (f) Body lotion (g) Face make-up and make-up remover products (h) Oral products (i) Deodorant products (spray/aerosol) [1]Check identity, concentration, exposure and use against the current legal annex and any amendments.
otherThe presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products. [1]Check identity, concentration, exposure and use against the current legal annex and any amendments.
SCCS opinion referenceOpinion concerning Essential Oils, Opinion concerning Fragrance Allergy in Consumers - A Review of the Problem - Analysis of the need for appropriate Consumer Information and Identification of Consumer Allergens, Opinion concerning the Interim Position on Fragrance Allergy, Memorandum on the SCCNFP Opinion concerning Fragrance Allergy, Opinion on Benzyl Salicylate (CAS No. 118-58-1, EC No. 204-262-9), preliminary version of 6-7 June 2023, final version of 26 October 2023, SCCS/1656/23. [1]Check identity, concentration, exposure and use against the current legal annex and any amendments.
Related regulation reference(EU) 2026/909 [1]Check identity, concentration, exposure and use against the current legal annex and any amendments.
Recorded publication date2026-04-28T00:00:00.000+0200 [1]Check identity, concentration, exposure and use against the current legal annex and any amendments.

Resolve the entry against your actual formula

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Does the supplied material fall within these exact entries?

    Put your supplier CAS/EC, substance composition, salt/group membership, purity, physical form and intended function beside each matched entry. A matching identifier does not resolve every group or impurity condition.

    Useful evidence: Supplier specification, composition and certificates of analysis; the exact annex rows above.

  2. Which row governs the finished-product use?

    Compare the finished-product concentration, body site, rinse-off/leave-on use, consumer/professional setting and any exposure restrictions with each row. Preserve the units and calculation basis; do not transfer a limit from a different product-use row.

    Useful evidence: Quantitative formula and use instructions; a row-by-row condition and warning worksheet.

  3. Is a prohibition or trace question involved?

    For Annex II matches, review Article 14 before formulation decisions. Article 17 concerns a separate, conditional non-intended trace situation; it does not grant blanket permission to intentionally add a prohibited substance. Record origin and technical-avoidability evidence for specialist review.

    Useful evidence: Ingredient/impurity origin, manufacturing controls, trace quantities and the cited Article 17 text.

  4. What must reach the safety assessor and Responsible Person?

    Send the reconciled identity, condition table, exposure facts, supplier evidence and unresolved amendment/date questions. Agree formula, assessment and PIF responsibilities before notification or manufacturing handoff.

    Useful evidence: A dated formula-evidence matrix, supplier data, exposure description and document ownership list.

Work packages and dependencies

What needs to happen first

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

EUR-Lex — Regulation (EU) 2009/1223 ↗

Consolidated text dated 2026-05-18 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D05 · snapshot fc7ca1c1b06e5052fbfd81afd57c8ba69d4c215a4fc4a2a8385b9bff94a7b591

  • [2] HTML table[2] in substantive document container (extraction legal-html-tables-2) / own tr[179] · record 7fb28628986dcbd94700b6de14966e4da1b9cce76d486f187302ae6305290a09
  • [3] #E0065 / containing div (linked annex note) · record 97497f75fa1c08c575c72b73276c303a80fdd594a57d08d83f51e29c2944c598
  • [4] HTML table[2] in substantive document container (extraction legal-html-tables-2) / own tr[180] · record 64fcbdf7a7f0ad21c7e7b4837e86d3bcac5a52826aa7b2f6b756abcb573dfc8d
  • [5] HTML table[2] in substantive document container (extraction legal-html-tables-2) / own tr[181] · record 22abb3f311108ae2117a78a76ede6c7012d12112e9b4cbc1076b7e8847d1ffbe
  • [6] HTML table[2] in substantive document container (extraction legal-html-tables-2) / own tr[182] · record cf5d1aea32c18d5d0b78e56964bdc4fb50a1229e841198fd26c9e5d5528eeeec
  • [7] HTML table[2] in substantive document container (extraction legal-html-tables-2) / own tr[183] · record 5488eac4ae02be92b848de307244172d82a1f61022a6ba5e48d5f26d42b2aa9c
  • [8] HTML table[2] in substantive document container (extraction legal-html-tables-2) / own tr[184] · record e1fc033874707d685017b9053de6fc992d90af3efbd1b550dc62e830bebcb6e8
  • [9] HTML table[2] in substantive document container (extraction legal-html-tables-2) / own tr[185] · record 15d3753a0b717e82feede9481fbb6a70046cd61f207f07ce95c95145ee47eb55
  • [10] HTML table[2] in substantive document container (extraction legal-html-tables-2) / own tr[186] · record cb26f88f22c127516fe67dc301ab4143c3430f3f560f2f045ecc7d43b758c50e
  • [11] HTML table[2] in substantive document container (extraction legal-html-tables-2) / own tr[187] · record e0e1c271741b8cd226d1fcdcc2d0f2246787c6ed8a463277f768828b795f2c95
  • [12] #art_14 · record 9ffeb5c563a32fe8d532de5d352c05f8a9062e1c5d21fd326d5e6c2ea42a84f4
  • [13] #art_17 · record 8ad3194ae1fc45e70495aa637f90457139a0023680e2b880fc4c8a8b4d202c43
  • [14] #art_10 · record 49eb173406b736d6f0b855572abc53b0f52d9543a4d170affa8ae68d6e809718
  • [15] #art_11 · record ba70c2a84c1d6c70eb57a0fd892fcdf584f6142281b03c29be4bd20e6e83844d

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare EU+UK Cosmetics Compliance

Cosmetic Contract Manufacturers & Private Label